))
Season 2 - Ep.15: Omega-3 fatty acids - Lead induced tricuspid regurgitation
Manage episode 417324162 series 3559418
Contenuto fornito da European Society of Cardiology. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da European Society of Cardiology o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
- Cardiology This Week: A concise summary of recent studies
- All you need to know about omega-3 fatty acids
- Lead induced tricuspid regurgitation
- MythBusters: Pomegranates are heart-healthy
Host: Rick Grobbee
Guests: Carlos Aguiar, Martin Andreas, Deepak Bhatt
Want to watch that episode? Go to: https://esc365.escardio.org/event/1150
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Martin Andreas has declared to have potential conflicts of interest to report: proctor/speaker/consultant (Edwards, Abbott, Medtronic, Boston, Braun, Zoll) and institutional Research Grants (Edwards, Abbott, Medtronic, LSI).
Deepak Bhatt has declared to have potential conflicts of interest to report: research funding from Amarin paid to Brigham and Women’s Hospital and the Icahn School of Medicine at Mount Sinai for my role as Principal Investigator of REDUCE-IT.
Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
42 episodi
Condividi
